PROM1 and colonic neoplasm: Furthermore, they reported that although both CD133+ and CD133− metastatic colon cancer cells can initiate tumors in NOD/SCID mice, CD133+ cells can give rise to the more aggressive CD133− cells during the metastatic transition [36].